SCHEMBL6686773

SCHEMBL6686773

NS(=O)(=O)c1cccc2[nH]c(=O)c3ccccc3c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 8/20 0.54
KDM4E B2RXH2 4/20 0.52
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
ALDH1A1 P00352 2/20 0.52
HSD17B10 Q99714 2/20 0.52
TNKS O95271 1/20 0.52
LMNA P02545 1/20 0.52
CYP1A2 P05177 1/20 0.52
GPR3 P46089 1/20 0.52
BLM P54132 1/20 0.52
PMP22 Q01453 1/20 0.52
PARP15 Q460N3 1/20 0.52
TNKS2 Q9H2K2 1/20 0.52
GRM6 O15303 1/20 0.49
GLA P06280 1/20 0.49
MAPT P10636 1/20 0.49
THRB P10828 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6685739 0.85 PARP1 (0.55) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL7714636 0.84 IMPDH2 (0.56) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL20227727 0.77 PARP1 (0.58) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL20597354 0.77 IMPDH2 (0.67) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL16530066 0.76 CA9 (0.44) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL8926269 0.73 PARP1 (0.60) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL11582792 0.72 PARP1 (0.57) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL2026877 0.72 CA1 (0.52) KDM4EKMT2AMEN1ALDH1A1HSD17B10
SCHEMBL23132415 0.72 PARP1 (0.64) PARP1KDM4EKMT2AMEN1ALDH1A1
SCHEMBL9747625 0.71 KMT2A (0.56) PARP1KDM4EKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6723733-B2 POLYMERASE INHIBITOR GUILFORD PHARMACEUTICALS, INC. 2004-04-20 US disclosed
US-20020006927-A1 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses EISAI INC. 2002-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020006927-A1 Sulfonamide and carbamide derivatives of 6(5H)phenanthridinones and their uses PARP1, PARP2, PARP6 PARP1 1/4885KDM4E 231/4885KMT2A 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.